Schedule 13D ownership disclosure

Intellia Therapeutics Inc

Security class unavailable · CUSIP: 45826J105

Event date: 2020-08-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-097257
Form type
SC 13D/A
Filer
Intellia Therapeutics, Inc.
CIK
CIK 1652130
Filed
Aug 20, 2020
Reporting period
Aug 06, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub